Clinical Trial Update: To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating DW1029M for microalbuminuria in diabetic nephropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• DW1029M (DW1029M)

Snippet

Sponsor: Dong Wha Pharmaceutical Co. Ltd. | Conditions: Diabetic Nephropathy | Phase 2 | Status: COMPLETED